c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals
The Wall Street Journal | Nov 4, 2026 3:57 PM EST
Rhythm specializes in treatments for metabolic conditions and severe obesity.
Read original article